Mr. Muneeb Ullah | Nanomedicine | Innovator in Pharmaceutical Research Award
Pusan National University | South Korea
Mr. Muneeb Ullah is a dedicated pharmaceutical scientist and research assistant at the Department of Pharmacy, Pusan National University, Busan, South Korea. His academic journey reflects a strong foundation in pharmaceutics, nanomedicine, and advanced drug delivery systems. With a Doctoral pursuit in Pharmacy at Pusan National University, his research focuses on nanoparticle preparation and novel therapeutic approaches for biofilm-associated wound healing, colon cancer, inflammatory bowel disease, and diabetic wound healing.Mr. Ullah’s earlier academic achievements include an MPhil in Pharmaceutical Sciences with a specialization in Pharmaceutical Nanotechnology from Kohat University of Science and Technology (KUST), Pakistan, where he conducted advanced research on the development of polymeric nanoparticles using the water-in-oil emulsion solvent evaporation method. His Pharm-D degree from KUST provided a robust grounding in pharmaceutics, pharmacology, biochemistry, and pharmaceutical chemistry, further shaping his expertise in nanotechnology-based therapeutics.Throughout his academic and professional career, he has demonstrated exceptional dedication and excellence. He has received several honors, including the Higher Education Commission Indigenous Scholarship, the Prime Minister Laptop Scheme’s Best Talent Award, the Best Teacher Award, and multiple Best Researcher Awards. His multidisciplinary experience includes teaching, research supervision, and laboratory expertise encompassing nanoparticle synthesis, animal handling for wound healing studies, HPLC, ELISA, UV spectrophotometry, zeta sizer analysis, and confocal microscopy.Mr. Ullah’s research contributions have significantly advanced the field of pharmaceutical nanotechnology. His publications span reputable journals and book chapters with publishers such as CRC Press and Academic Press. His works explore diverse topics, including genetic engineering of fungi, sugar nanocluster adhesives for diabetic wound healing, advancements in 3D and 4D bioprinting for sustained drug delivery, biomedical applications of carbon dots, tumor microenvironment biology, gastrointestinal inflammation, and nanoparticle-based oral cancer therapies. His studies on alginate-based tumor-selective nanoparticle delivery and cancer nanomedicine have been widely cited for their innovation and translational potential.To date, Mr. Ullah has contributed to 37 scholarly documents, amassing a total of 470 citations, with an h-index of 11, reflecting the influence and recognition of his research in the global scientific community. With this growing research impact, he continues to contribute to cutting-edge pharmaceutical research with a vision to design smarter, safer, and more efficient nanotherapeutics that bridge the gap between laboratory innovation and clinical application.
Profile: Scopus
Featured Publications
Author(s). (2025). Leukocyte esterase-activated nanoconjugates enables precise local therapy of ulcerative colitis via inflamed tissue-selective drug delivery. ACS Applied Materials and Interfaces.
Author(s). (2025). Sugar nanocluster adhesive boosts wound healing in diabetic mice. Carbohydrate Polymer Technologies and Applications.
Author(s). (2025). Genetic engineering of fungi.